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The initiation  of many antigen-specific,  T-dependent  immune  responses  requires 
the  participation  of accessory cells  that  express  Ia antigens  (1,  2).  Recent  evidence 
indicates that the Ia antigen expression of macrophages, a principle class of accessory 
cells,  is  regulated  by  lymphokines:  Steinman  et  al.  (3)  have  reported  that  culture 
supernatants  of Trypanosoma  cruzi-activated  spleen  cells  enhanced  the  synthesis  and 
expression  of Ia  antigens  by  murine  macrophages  in  vitro.  Steeg  et  al.  (4)  have 
observed that culture supernatants  of concanavalin A-stimulated spleen cells (Con A 
supernatant) 1 induced  Ia-  murine  thioglycollate-elicited  peritoneal  exudate  macro- 
phages  to  express  Ia  antigens  in  vitro.  Macrophages  incubated  with  lymphokine- 
containing culture supernatants developed the capacity to initiate the mixed leukocyte 
reaction (4) and the antigen-specific activation of helper T  lymphocytes (5, 6). Finally, 
Scher et  al.  (7)  have reported  that  intraperitoneal  injections of culture supernatants 
of Listeria monocytogenes-stimulated lymphocytes induced peritoneal  exudates  that  are 
enriched in Ia  + macrophages. 
Identification of the lymphokine(s)  that modulates macrophage Ia antigen expres- 
sion has been hampered by the plethora of lymphokine activities present  in relatively 
low titers  and  high-protein  contents  of the  lymphokine-containing culture  superna- 
tants.  This  paper  characterizes  the  macrophage  Ia  antigen  regulatory  mediator 
present in the Con A  supernatant  and demonstrates that the macrophage Ia antigen 
regulatory mediator shares antigenic (8) and biochemical characteristics with immune 
interferon  (IFN-7).  Furthermore,  independently  prepared  IFN-y, purified  to  10  7 U/ 
mg protein  specific activity,  both  induced  and  maintained  macrophage  Ia  antigen 
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expression in vitro. Finally, we present evidence that a  number of other lymphokines 
present in the Con A supernatant have no macrophage Ia antigen regulatory activity. 
Materials  and  Methods 
Induction of Macrophage Ia Antigen Expression•  P388D1  macrophages (9) were maintained in 
RPMI  1640  (Flow Laboratories, Inc.,  Rockville, MD)  containing  5%  fetal calf serum  (lot 
100308;  Sterile Systems Inc., Logan UT) and antibiotics (medium)• The cells were maintained 
at a density of 5 ×  l0  s cells/ml in roller bottles (Costar, Data Packaging, Cambridge, MA) at 
37°C on a shaking apparatus. To induce Ia antigen expression, 1 ×  104 macrophages in 0.2 ml 
enriched  McCoys  5-A  medium  for  granulocyte/macrophage culture  (10)  containing serial 
dilutions of Con  A  supernatant  were  incubated  in  wells of microtiter plates  (Costar Data 
Packaging) for 2-3 d at 37°C in a humidified atmosphere of 5% CO2 in air. The percentage of 
Ia  + macrophages was determined by removal of the culture supernatants and incubation of the 
•  •  d  macrophages with monoclonal antl-I-A  (clone 25-9-17,  kindly provided by Dr. David Sachs, 
National Institutes of Health, or B6AF1 anti-B10.D2, kindly provided by Dr. John  Kappler, 
Dept. of Medicine, National Jewish Hospital) in 50 ~1 RPMI  1640 for 1 h at 4°C, followed by 
a second removal of the culture supernatants and incubation of the cultures with 50/11 of Low 
Tox M  rabbit complement (Cedarlane Laboratories, Hicksville, NY)  at a  1:10 or  1:15  final 
dilution for 1 h at 37°C. Viability was determined by trypan blue exclusion, with at least 100 
cells per microtiter well scored. Each treatment was assayed in triplicate, with an additional 
complement control (typically  <5% nonspecific cytotoxicity),  and the data are expressed as the 
mean cytotoxicity index (CI) (4) with 95% confidence limits, based on arcsine square transfor- 
mation. 
Interferon Assay.  Interferon (IFN) levels were quantified by a modification (11) of the viral 
plaque reduction assay of Wagner  (12).  The  IFN titer  (expressed as units  per milliliter) is 
defined as the reciprocal of the log culture supernatant  dilution resulting in  a  50%  plaque 
reduction as compared with control cultures, calculated by linear regression. The IFN assay 
was calibrated using WHO  international IFN reference standard G-002-9-04-511  (Research 
Resources Branch, National Institute of Allergy and Infectious Diseases, National Institutes of 
Health). 
Lymphokines.  Con  A-stimulated spleen cell supernatants were prepared using C3H/HeN 
(Ia  k) spleen cells and adsorbed with Sephadex G-10 as previously described (4).  For chroma- 
tography, supernatants were concentrated by ultrafiltration using immersible CX-10 ultrafil- 
tration units (Millipore Corp., Bedford, MA). Parially purified IFN-y (sp ac  10  7 U/mg protein) 
was prepared from staphylococcal enterotoxin A-stimulated spleen cell culture supernatants by 
sequential controlled pore glass, Con A Sepharose, and AcA54 gel filtration chromatography as 
described (13).  Other reagents tested for macrophage Ia antigen regulatory activity included 
(a) L cell IFN, the culture supernatant of polyinosinic acid:polycytidylic  acid-stimulated L929 
fibroblasts (14),  was tested as both  a  crude supernatant  and  in  partially purified form,  by 
sequential ammonium sulfate precipitation, Affigel 202 chromatography, and polyuridylic acid 
Sepharose chromatography (15);  (b) IFN-? containing phorbol myristic acetate (PMA)-stimu- 
lated BFS T lymphocyte cell line supernatants were pH 2 treated, trypsin treated, and partially 
purified by isoelectric focusing as described (11);  (c)  interleukin 2  (IL-2) and  macrophage- 
granulocyte colony-stimulating factor (CSF) were prepared from serum-free culture superna- 
tants of PMA-stimulated EL4 thymoma cells by absorption with activated charcoal, ammonium 
sulfate precipitation, and phenyl Sepharose chromatography as described (16);  (d) macrophage- 
activating factor (MAF), as defined by the capacity to induce macrophages to kill tumor cells 
(17),  was  obtained  from  serum  containing  culture  supernatants  of PMA-stimulated  EL4 
thymoma  cells  and  was  partially purified  by  AcA54  gel  filtration  chromatography; 2  (e) 
epidermal cell-derived thymocyte-activating factor (ETAF) was obtained from unstimulated 
culture supernatants of PAM 212 cells and was partially purified by Sephacryl S-200 superfine 
gel filtration chromatography as described (18). 
z Meltzer, M. S., W. R.  Benjamin,  and J. J.  Farrar. Macrophage  activation  for tumor cytotoxicity: 
induction  of macrophage  tumoricidal  activity by lymphokines  from  El-4,  a  continuous  T  cell  line. 
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Gel Filtration Chromatography.  2  ml of a  20×-concentrated Con A  supernatant was  passed 
over a  2.6- X  100-cm Sephacryl S-200 superfine (Pharmacia Fine Chemicals, Piscataway, N  J) 
gel filtration column at a  rate of 20 ml/h at 4°C. The column was previously equilibrated in 
0.10 M  NaCl, 0.05 M Tris, pH 7.5 buffer, and calibrated with blue dextran (exclusion marker), 
bovine serum albumin (67,000 Mr), ovalbumin (43,500 Mr), and cytochrome c (12,384 Mr). 4- 
ml fractions were collected and brought to  1% final concentration fetal calf serum (FCS) after 
OD280 determinations. The fractions were then filter sterilized and assayed for macrophage Ia 
antigen regulatory activity (at final concentrations of 10-',  10  -2, and  10  -3)  and IFN antiviral 
activity. 
Isoelectric Focusing.  A  50-ml Con A  supernatant was  focused  using a  100-ml preparative 
isoelectric  focusing column  (LKB  Laboratories,  Gaithersburg,  MD)  as  previously described 
(11).  The 2-ml fractions were assayed for macrophage Ia antigen regulatory activity (at final 
concentrations of 1:5,  1:10, and 1:50)  and IFN antiviral activity. 
Phenyl Sepharose Chromatography.  A  1-ml 10X-concentrated Con A supernatant was fraction- 
ated by phenyl Sepharose chromatography  as previously described  (16).  The  2-ml fractions 
were  assayed  for macrophage Ia antigen regulatory activity (at  final concentrations of 10  -~, 
10  -2, and 10  -a) and IFN antiviral activity. 
Polyuridylic Acid Sepharose Chromatography.  A  0.5-ml, 20X-concentrated Con A  supernatant 
was fractionated by polyuridylic acid  (poly U)  Sepharose chromatography  as described  (19, 
20).  The 2-ml fractions were assayed for macrophage Ia antigen regulatory activity (at  final 
dilutions of 10  -1,  10  -2, and 10  -a) and IFN antiviral activity. 
Chromatography Controls.  As a control for possible nonspecific binding to Sepharose, Sepharose 
(CL-4B;  Pharmacia  Fine Chemicals)  was swollen and equilibrated in each chromatography 
buffers.  1 ml of 10×-concentrated Con A supernatant was dialyzed for 24 h at 4°C against 100 
vol of the appropriate buffer, applied to the Sepharose column, and eluted with the appropriate 
buffer.  Fractions were  brought  to  1%  FCS,  dialyzed  for  24  h  against  50  vol of phosphate- 
buffered  saline  (PBS),  filter  sterilized,  and  assayed  for  macrophage  Ia  antigen  regulatory 
activity (at  1:5,  1:10, and 1:40 final concentrations) and IFN antiviral activity. 
Antibody Neutralization Experiments.  Two conventional antisera were used in this study:  (a) 
goat  anti-mouse type  I  IFN  antiserum  (Research  Resources  Branch,  National  Institute of 
Allergy and Infectious Diseases) neutralizes IFN-a and IFN-fi, but not IFN-y; (b) rabbit anti- 
mouse IFN-~, antiserum prepared against staphlococcal enterotoxin A-induced IFN-y partially 
purified to  107 U/mg protein specific activity (21)  was subsequently absorbed against spleen 
cells and FCS as described  (22).  This antiserum neutralizes mitogen and mixed lymphocyte 
reaction-induced IFN, but not virally induced IFN (21).  In addition, when Con A supernatants 
were absorbed for  1 h  at 4°C with sufficient antisera to neutralize twice the number of IFN 
units present, significant reductions in the  dose-response curves for the  interleukin 1 (IL-I), 
interleukin 2 (IL-2), and CSF bioassays (22)  as well as MIF (R. Mouhon, personal communi- 
cation) and MAF (M. Mehzer, personal communication) assays were not obtained, as compared 
with absorption of a Con A supernatant with a control normal rabbit serum. For macrophage 
Ia antigen regulatory activity experiments, l-ml aliquots ofa 1:40 dilution of Con A supernatant 
were incubated with antiserum or control serum (starting with sufficient antiserum to neutralize 
double the IFN units contained in the preparation) at 4°C for  1 h. The culture supernatants 
were then assayed for macrophage Ia antigen regulatory activity and IFN activity. 
Additional Treatments.  To determine the pH stability of the macrophage Ia antigen regulatory 
lymphokine, 1-ml Con A supernatants were dialyzed for 24 h at 4°C against 100 vol of 0.1  0.2 
M  Tris-glycine, sodium acetate, sodium citrate, potassium phosphate, and borate buffers with 
pHs ranging from 2 to  10. The supernatants were then dialyzed for an additional 24 h at 4°C 
against  100  vol of PBS,  filter sterilized,  and assayed  for  macrophage  Ia  antigen regulatory 
activity (at  1:5,  1:10, and 1:50 final concentrations) and 1FN antiviral activity. 
The  heat  stability of the  macrophage  Ia  antigen regulatory  activity was  determined  by 
incubating 1-ml Con A supernatants at either 37 or 56°C for 1 h, and cooling immediately. 
To determine the sensitivity of the macrophage Ia antigen regulatory activity to trypsin, 0.7 
ml of Con A  supernatant was treated with either  10 U  of bovine pancreas trypsin or RNase 
attached  to cross-linked beaded agarose  (Sigma Chemical Co.,  St.  Louis, MO)  as previously STEEG  ET  AL.  1783 
described  (11). The supernatants were tested for Ia antigen regulatory activity (at  1:10, 1:50, 
and 1:250 final concentrations) and for IFN antiviral activity. 
Results 
Assay for Lymphokine Induction of Macrophage Ia Antigen Expression.  A modified assay 
for lymphokine induction of macrophage Ia antigen expression was  developed (8), 
using the Ia- P388Dx macrophage cell line as a target cell rather than thioglycollate- 
induced peritoneal exudate macrophages. In the experiment shown in Table I, P388D1 
macrophages (Ia  d) were incubated for 2 d  with dilutions of Con A supernatant or a 
control supernatant prepared from C3H/HeN (Ia  k) spleen cells, and the percentage 
of cells  expressing  LA  d  antigens  was  determined.  As  shown,  incubation  of the 
macrophages  with  Con  A  supernatant  induced  endogenously  derived  Ia  antigen 
expression in a dose-dependent manner. The sensitivity of this assay is a CI of 6, and 
its precision is  7%.  The use of the  P388D1 cell line as a  target cell in  this assay is 
advantageous (a) as a source of macrophages free of other contaminating cell types, 
(b) as a homogeneous source of Ia- cells, and (c) because P388D1 cells can be grown 
in suspension culture, permitting cell recovery without cell surface damage resulting 
from trypsinization or scraping. 
Characterization of the Con A  Supernatant Macrophage Ia Antigen Regulatory and IFN-y 
Activities.  Using this assay, the macrophage Ia antigen regulatory mediator(s) in the 
Con  A  supernatant  has  been analyzed to determine its biochemical and  antigenic 
characteristics, which are summarized in Table II. Also shown are the characteristics 
of the  Con  A  supernatant  IFN  antiviral  activity,  quantified  by  a  viral  plaque 
reduction  assay.  Plusses  (+)  in  this  table  indicate that  the Con  A  supernatant,  as 
treated, had significant biological activity in the indicated assay and that the activity 
was detectable in a dose-dependent manner. 
Table  II  indicates  that  both  the  Con  A  supernatant  macrophage  Ia  antigen 
regulatory and IFN-T activities were trypsin sensitive, sensitive to overnight dialysis 
to pH 2 and 3 buffers, resistant to dialysis to pH 4-10 buffers, and resistant to heating 
at 56°C for 1 h. 
Gel filtration chromatography of the Con A supernatant is shown in Fig.  1. Both 
the macrophage Ia  antigen  regulatory and  IFN-y activities eluted  from Sephacryl 
TABLE  I 
Con A Supernatant Induction of P388Dl Macrophage la Antigen Expression 
Supernatant 
dilution 
Mean CI (95% confidence limits) 
Con A supernatant*  Controlsupernatant~ 
0  0  0 
1:20  56.8 (54.5, 59.1)§  0 
1:80  64.4 (56.5, 72.3)§  2.9 (2.2, 3.7) 
1:320  12.8  (10.7,  14.9)  0 
1:1,280  0.5 (0, 2.3)  0 
P388D1 (Ia  a) macrophages were incubated 2 d with supernatant prepared from C3H/HeN 
(Ia  k)  spleen cells, and  the percentage of Iad expressing macrophages  was determined  by 
anti-I-A and complement-mediated cytotoxicity. 
* Con A-stimulated spleen cell supernatant  (4). 
:~ Con A-supplemented  (unstimulated) spleen cell supernatant. 
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TABLE II 
Characterization of the Con A Supernatant: Properties of the Macrophage Ia Antigen  Regulatory Activity 
that Are Shared with the Interferon Antiviral  Activity 
Macrophage Ia  IFN antiviral 
Property*  antigen regula- 
tory activity  activity 
pH 2-3 sensitive; pH 4-10 resistant 
Resistant to 56°C,  1 h 
Trypsin sensitive 
RNase resistant 
40,000  apparent  molecular weight on Sephacryl S-200 
Superfine 
pI =  5.0  5.5 
Binds phenyl Sepharose; elutes at 35% ethanediol 
Binds poly U  Sepharose; elutes in high-sah buffer 
Binds Sepharose 
Neutralized by goat anti-mouse type I IFN antiserum 
Neutralized by rabbit anti-mouse IFN-y antiserum 
+~  + 
+  + 
+  + 
+  + 
+  + 
+  + 
+  + 
+  + 
+  + 
* See Materials and Methods. 
Plusses (+) signify that the Con A supernatant, as treated, had significant, dose-dependent activity in the 
indicated bioassay. 
S-200 Superfine columns with an apparent molecular weight of 40,000.  Background 
Ia  antigen  induction  below  the  sensitivity  of the  assay  (CI  <6.0),  and  therefore 
insignificant, was found scattered throughout  the fractions. The apparent molecular 
weight  of  IFN-  7  obtained  in  this  experiment  is  consistent  with  other  estimated 
molecular weights for IFN-y, which vary from 20,000 to 60,000, but are most often in 
the 40,000-50,000  range (23). 
Hydrophobic chromatography of the Con A  supernatant  macrophage Ia antigen 
regulatory and  IFN-T activities on  phenyl  Sepharose are shown  in  Fig.  2.  A  major 
peak of macrophage Ia antigen  regulatory activity and IFN-7 activity bound  to the 
phenyl Sepharose and co-eluted at ~35% ethanediol.  Minor levels of macrophage Ia 
antigen-inducing activity eluted in the initial part of the ethanediol gradient and co- 
eluted with titers of IFN-y of <5 U/ml  (data not shown). 
Isoelectric  focusing  of  the  Con  A  supernatant  is  shown  in  Fig.  3.  Both  the 
macrophage Ia antigen regulatory and IFN-y activities of the Con A supernatant had 
an isoelectric point  (pI) between pH 5.0 and 5.5.  The heterogeneity exhibited in this 
peak is consistent with previous reports for other interferons (24). 
Fibroblast IFN (19)  and more recently IFN-y (20)  have been reported to reversibly 
bind  poly  U  Sepharose.  Fig.  4  demonstrates  the  elution  pattern  of  the  Con  A 
supernatant  macrophage  Ia  antigen  regulatory  and  IFN-y  activities  on  poly  U 
Sepharose.  As  shown,  both  activities  are  retained  by  the  poly  U  Sepharose,  and 
subsequently eo-elute after the application of a high-salt buffer. 
The  antigenic  characteristics  of the  Con  A  supernatant  macrophage  Ia  antigen 
regulatory and IFN-  7  activities have been determined.  Table II indicates  that  goat 
anti-mouse  type  I  IFN  antiserum,  which  neutralizes  IFN-a  and  IFN-/~,  does  not 
neutralize either the macrophage Ia antigen  regulatory or IFN activities of the Con 
A supernatant. Table III demonstrates the effect of a rabbit anti-IFN-y antiserum on 
these bioactivities. Con A supernatants were adsorbed with dilutions of antiserum for STEEG ET  AL. 
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FIG.  1.  Gel filtration chromatography  of the Con A supernatant.  A 2-ml, 20×-concentrated  Con 
A supernatant  was applied to a Sephacryl S-200 Superfine column and eluted with 0.05 M Tris- 
HCI, 0.1 M NaC1 buffer, pH 7.5. Alternate fractions were assayed for IFN activity and induction of 
P388D] macrophage Ia antigen expression as determined by antibody- and complement-mediated 
cytotoxicity (1:100 dilution  shown). The peak fractions had a specific activity of 80 U IFN/OD 
unit, and represented a 41% recovery of the applied IFN sample, 
1  h  at  4°C  and  subsequently  incubated  with  P388Da  cells  to  induce  Ia  antigen 
expression. As shown, the anti-IFN-y antiserum inhibited Con A  supernatant  induc- 
tion of P388D1  macrophage  Ia antigen  expression to a  CI of 5.4,  a  level below the 
sensitivity of the assay and therefore indistinguishable from untreated macrophages. 
The IFN-y content of the Con A  supernatant  was also abrogated  (data not shown). 
Absorption of the Con A  supernatant with normal rabbit serum did not abrogate its 
macrophage Ia antigen regulatory and IFN-y activities. 
Macrophage Ia Antigen Regulatory Activity of Partially Purified IFN-  y.  An independently 
prepared murine IFN-y purified to  107 U/rag protein specific activity was tested for 
Ia antigen regulatory activity (Fig. 5, panel A). P388D1  macrophages were incubated 
with  serial dilutions of IFN-y for 3  d,  and  the  percentage  of Ia  +  macrophages  was 
determined. As shown, a  dose-dependent induction of macrophage Ia antigen expres- 
sion  occurred.  Such  Ia  +  macrophages,  if  subsequently  reincubated  with  IFN-y, 
remained Ia  + but reverted to the Ia- state if reincubated in IFN-y-free medium (data 
not  shown).  Thus,  IFN-y purified to  107  U/mg  protein specific activity has  macro- 1786  LYMPHOKINE  REGULATION OF  MACROPHAGE  Ia  ANTIGEN  EXPRESSION 
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Fro.  2.  Hydrophobic chromatography of the Con A supernatant. A  1-ml,  10X-concentrated Cola 
A supernatant was applied  to a  phenyl Sepharose column, which was then washed with 0.8  M 
(NH4)2SO4  in  0.02  M  PBS.  Fractions were  assayed  for  IFN  content  and  inductionof P388D] 
macrophage Ia antigen expression as determined by antibody- and complement-mediated cytotox- 
icity (l:100 dilution shown). The peak fractions had a  specific  activity of 97  U  IFN/OD unit and 
represented a 29% recovery of the IFN in the starting material. 
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phage Ia antigen regulatory activity. 
Role of Other Lymphokines in the Regulation of Macrophage Ia Antigen Expression.  Another 
approach to identify the lymphokine(s) that induces macrophage Ia antigen expression 
was to assay the effect of culture supernatants known to contain a limited number of 
lymphokine activities. Recently, an IL-2-independent T  cell line (BFS) was isolated 
that produces IFN-y upon stimulation with PMA  (11).  Culture supernatants of this 
cell line, however, do not contain detectable CSF, IL-1, IL-2, B cell growth factor, or 
T  cell replacing factor  (11).  Fig.  5  (panel  B)  indicates  that  P388Dx  macrophages, 
when incubated with crude or partially purified BFS culture supernatants, expressed 
Ia antigens in a dose-dependent manner. The Ia antigen-inducing activity of the BFS 
cell line supernatant was sensitive to trypsin treatment and pH 2 dialysis. Thus, an 
IFN-y-like lymphokine can regulate macrophage Ia antigen expression without  the 
participation of a number of other known lymphokines. 
Subsequent experiments investigated whether a non-IFN lymphokine can directly 
regulate macrophage Ia antigen expression. The following lymphokine preparations, 
which were devoid of detectable IFN-y activity, had  no detectable macrophage Ia 
antigen  regulatory activity  (data  not  shown):  (a)  EL4  thymoma  cell-line-derived, 
partially-purified CSF  (1-10,000 U/ml)  or IL-2  (1-100 U/ml);  (b)  PAM  212  cell- 
line-derived ETAF, over a  3-log range of dilutions.  Data indicating that  these cell- 
line-derived mediators are representative of those found in the Con A supernatant is 
provided by the inhibition of Con A supernatant macrophage Ia antigen regulatory 
activity by rabbit anti-mouse IFN-y antiserum, which does not inhibit the IL-I, IL-2, ~
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TABLE  III 
Abrogation of Con A Supernatant Induction of Macrophage Ia Antigen Expression by Rabbit 
Anti-IFN- 7 Antiserum  * 
1789 
Serum dilution 
Mean CI (95% confidence limits) 
Con A supernatant +  rabbit 
anti-•  serum~ 
Con A supernatant +  normal 
rabbit serumS: 
0  55.08 (4.9, 66.o) 
1:16  37.94 (19.7, 58.1)  (46.11  (37.2, 55.6) 
1:8  17.12  (10.4, 25.1)  46.48 (34.2, 59.8) 
1:4  4.42  (0.2,  16.8)  51.36 (40.8, 61.8)§ 
* Con A supernatant (1:40 dilution) and either antiserum or control serum were incubated 
for  1 h  at 4°C. The mixtures were then incubated with P388DI macrophages for 2 d, and 
the percentage of Ia  + macrophages was determined by antibody- and complement-medi- 
ated cytotoxicity. 
:~ Neither serum was directly cytotoxic at the concentrations shown. 
§ Differs significantly (P <  0.01)  from  Con  A  supernatant  +  normal  rabbit  serum,  not 
significantly different (P <  0.05) from untreated macrophages. 
or  CSF  bioassays  (22);  (c)  a  crude  macrophage  MIF  preparation,  prepared  by 
absorbing the Con A supernatant with rabbit anti-mouse IFN-  7 antibody (R. Moul- 
ton, unpublished observation) (d) a crude MAF preparation, prepared by absorption 
of the Con A  supernatant with rabbit  anti-mouse IFN-  7  (M.  S.  Mehzer, personal 
communication) when tested in serial dilutions ranging from 1:20 to 1:1,000. However, 
culture  supernatants  of PMA-stimulated  EL4  thymoma cells,  upon  gel  filtration, 
yield two peaks  of MAF activity:  2 (a)  a  low molecular weight  peak  that  had  no 
detectable IFN activity, nor (at final concentrations of 1:2-1:100)  any macrophage Ia 
antigen regulatory activity; and (b)  a second higher molecular weight peak of MAF 
activity that co-eluted with IFN-  7 activity-induced P388Dx  macrophage Ia antigen 
expression. It is not yet known whether both MAF activities are also present in the 
Con A  supernatant.  Thus,  it  appears  that  IFN-  7  and  the  macrophage  Ia  antigen 
regulatory activity can be separated from at least one MAF activity. 
Macrophage  Ia  Antigen  Regulatory  activity of Other IFN Preparations.  L  cell IFN, the 
culture  supernatants of polyinosinic acid:polycytidylic acid-stimulated L929  fibro- 
blasts, were tested for macrophage Ia antigen regulatory activity in both crude and 
partially purified forms. L cell IFN, in a dose-dependent manner typically induced a 
maximum  of only  10-15%  Ia  ÷  P388D1  macrophages  (Fig.  5,  panel  C).  Optimal 
macrophage Ia antigen-inducing activity typically occurred between 0.4 and 4.0 U/ 
ml IFN activity and was reduced at higher IFN concentrations. 
Discussion 
The data indicate that  an IFN-7-1ike  molecule present  in a  Con A  supernatant 
regulates the in vitro expression of Ia antigens on macrophages. This molecule shares 
molecular weight, pI, and hydrophobic, affinity, and antigenic characteristics with 
the antiviral activity of the Con A supernatant. Further, an independently prepared 
partially  purified  IFN-y  (107 U/mg  protein  sp  act)  has  macrophage  Ia  antigen 
regulatory activity. 
A number of other lymphokines present in the Con A supernatant had no detectable 
macrophage Ia antigen regulatory activity. These data are based on:  (a)  the lack of 7
0
 
8
o
 
i
 
*
1
 
4
0
 
o
 
1
0
 
/
 
i
 
i
 
i
 
i
 
0
 
0
.
2
5
 
1
 
4
 
1
6
 
A
 
B
 
C
 
j
 
_
I
 
0
 
0
.
2
5
 
0
.
5
 
1
 
2
 
0
 
0
.
2
5
 
1
 
4
 
1
6
 
F
r
o
.
 
5
.
 
I
n
d
u
c
t
i
o
n
 
o
f
 
m
a
c
r
o
p
h
a
g
e
 
I
a
 
a
n
t
i
g
e
n
 
e
x
p
r
e
s
s
i
o
n
 
b
y
 
i
n
d
e
p
e
n
d
e
n
t
l
y
 
p
r
e
-
 
p
a
r
e
d
 
I
F
N
,
 
P
3
8
8
D
i
 
m
a
c
r
o
p
h
a
g
e
s
 
w
e
r
e
 
i
n
c
u
b
a
t
e
d
 
f
o
r
 
3
 
d
 
w
i
t
h
 
d
i
l
u
t
i
o
n
s
 
o
f
 
I
F
N
,
 
a
n
d
 
t
h
e
 
p
e
r
c
e
n
t
a
g
e
 
o
f
 
l
a
 
+
 
m
a
c
r
o
p
h
a
g
e
s
 
w
a
s
 
d
e
t
e
r
m
i
n
e
d
 
b
y
 
a
n
t
i
b
o
d
y
-
 
a
n
d
 
c
o
m
-
 
p
l
e
m
e
n
t
-
m
e
d
i
a
t
e
d
 
c
y
t
o
t
o
x
i
c
i
t
y
.
 
P
a
n
e
l
 
A
:
 
S
t
a
p
h
l
o
c
o
c
c
a
l
 
e
n
t
e
r
o
t
o
x
i
n
 
A
-
i
n
d
u
c
e
d
 
I
F
N
-
7
,
 
p
u
r
i
f
i
e
d
 
t
o
 
1
0
7
 
U
/
r
a
g
 
p
r
o
t
e
i
n
 
s
p
 
a
c
t
;
 
p
a
n
e
l
 
B
:
 
I
F
N
+
y
-
c
o
n
t
a
i
n
i
n
g
 
B
F
S
 
c
e
l
l
 
l
i
n
e
 
c
u
l
t
u
r
e
 
s
u
p
e
r
n
a
t
a
n
t
s
.
 
(
-
-
)
 
c
r
u
d
e
 
c
u
h
u
r
e
 
s
u
p
e
r
n
a
t
a
n
t
;
 
(
 
.
.
.
.
.
 
)
 
p
l
 
1
 
2
-
t
r
e
a
t
e
d
 
c
u
h
u
r
e
 
s
u
p
e
r
n
a
t
a
n
t
;
 
(
 
-
)
 
t
r
y
p
s
i
n
-
t
r
e
a
t
e
d
 
c
u
h
u
r
e
 
s
u
p
e
m
a
t
a
n
t
;
 
(
-
-
-
 
-
-
)
 
I
E
F
 
p
e
a
k
 
o
f
 
c
u
l
t
u
r
e
 
s
u
p
e
r
n
a
t
a
n
t
.
 
P
a
n
e
l
 
C
:
 
p
o
l
y
i
n
o
s
i
n
i
c
 
a
c
i
d
:
p
o
l
y
c
i
t
i
d
y
l
i
c
 
a
c
i
d
 
s
t
i
m
u
l
a
t
e
d
 
L
9
2
9
 
f
i
b
r
o
b
l
a
s
t
 
d
e
r
i
v
e
d
 
I
F
N
,
 
p
a
r
t
i
a
l
l
y
 
p
u
r
i
f
i
e
d
 
b
y
 
s
e
q
u
e
n
t
i
a
l
 
a
m
m
o
n
i
u
m
 
s
u
l
f
a
t
e
 
p
r
e
c
i
p
i
t
a
t
i
o
n
 
a
n
d
 
A
t
t
i
g
e
l
 
2
0
2
 
a
n
d
 
p
o
l
y
 
U
 
S
e
p
h
a
r
o
s
e
 
c
h
r
o
m
a
t
o
g
r
a
p
h
y
.
 
-
,
,
.
a
 
¢
D
 
O
 
m
 
0
 
©
 
C
 
>
 
,
.
-
+
 
Z
 
©
 
>
 
©
 
©
 
>
 
©
 
>
 
Z
 
Z
 
×
 
¢
+
q
+
 
2
1
 STEEG  ET  AL.  1791 
macrophage Ia antigen regulatory activity in culture supernatants of cell lines known 
to contain a limited number of lymphokine activities;  and (b)  the inhibition of the 
Con A supernatant macrophage Ia antigen regulatory activity by rabbit anti-IFN-y, 
without significant reductions in the titers of a number of other lymphokines present 
in this supernatant. The data, therefore, suggest that IL-1, IL-2, CSF, MIF, and MAF 
with biochemical and antigenic characteristics distinct from those of IFN-y have no 
macrophage Ia antigen regulatory activity. However, the data do not preclude the 
existence  of other  lymphokines besides  IFN-y  that  are  biochemically similar  to 
IFN-y  and  may  have  the  capacity  to  directly  regulate  macrophage  Ia  antigen 
expression,  such as the high molecular weight MAF activity, or the possibility the 
IFN-y can act synergistically with a co-factor. 
Experiments in  progress,  which examine the capacity of cloned human IFN to 
induce DR antigen expression on human monocytes and monocytic cell lines, indicate 
that cloned IFN can regulate human macrophage DR antigen expression. Using these 
data, we  postulate that  an  IFN-y-like molecule regulates macrophage Ia  antigen 
expression in vivo. It has been reported that the Ia antigen expression of macrophages 
from various tissues  differs:  for example, splenic  (25), thymic (26), and  liver  (27) 
macrophages are mainly Ia  +, whereas exudate macrophages are predominantly Ia- 
(25, 28). It can be hypothesized that in those tissues in which a high proportion of Ia  + 
macrophages  reside,  continuous  low-level  production  of an  IFN-y-like  mediator 
induces and maintains macrophage Ia antigen expression. The observation that mice 
reared in a specific-pathogen-free  environment have reduced macrophage Ia antigen 
expression  (29) suggests that the background barrage of antigenic stimuli normally 
encountered may stimulate the continuous low-level lymphokine production. Fur- 
thermore, several reports suggest the intriguing possibility that the autoimmune state 
may, in part, be regulated by IFN modulation of macrophage Ia antigen expression, 
and consequent enhanced presentation of self-antigens:  (a)  autoimmune MRL/lpr 
mice have higher percentages of Ia  + resident macrophages than normal MRL/+++ 
mice (30); (b)  active systemic lupus erythematosis patients have higher serum IFN 
titers than patients with an inactive disease state (31); and (c) normal mice that were 
neonatally thymectomized and injected with the IFN inducers poly I:C plus lipopoly- 
saccharide developed autoimmune disease (32). Experiments in progress are examin- 
ing in detail the suggested  in vivo correlation of serum IFN titers, macrophage Ia 
antigen expression, and autoimmunity. 
Summary 
A culture supernatant of  concanavalin A-activated spleen cells (Con A supernatant) 
induced murine macrophages to express Ia antigens in vitro.  Biochemical character- 
ization of  the Con A supernatant indicated that the macrophage Ia antigen regulatory 
activity shares  molecular weight, pI,  and  hydrophobic and affinity characteristics 
with immune interferon (IFN-7).  Antiserum to mouse IFN-y neutralized both the 
macrophage Ia antigen regulatory and IFNq, bioactivities of the Con A supernatant. 
Furthermore, both partially purified murine IFN-y (10  7 U/mg protein sp act)  and 
IFN-containing culture supernatants of the murine BFS T  cell line-induced macro- 
phage Ia antigen expression  in vitro.  Culture supernatants containing colony-stimu- 
lating factor, interleukin  l, interleukin 2, macrophage migration inhibitory factor, 
and a macrophage-activating activity that were distinct from IFN-y did not induce 1792  LYMPHOKINE  REGULATION OF  MACROPHAGE Ia ANTIGEN EXPRESSION 
macrophage Ia antigen expression. Taken together, the data indicate that the in vitro 
expression of Ia  antigens on  macrophages  is  regulated by an  activity that  has  the 
characteristics of interferon. 
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